Lupin Limited
Lupin is a USD 2.09 billion innovation led transnational pharmaceutical major producing and developing a wide range of specialty and generic formulations as well as biotechnology products and APIs globally. The Company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership positions in the Anti-TB and Cephalosporin segment